ATE289203T1 - Behandlung von konjunktivitis mit histacalin proteinen - Google Patents

Behandlung von konjunktivitis mit histacalin proteinen

Info

Publication number
ATE289203T1
ATE289203T1 AT00954784T AT00954784T ATE289203T1 AT E289203 T1 ATE289203 T1 AT E289203T1 AT 00954784 T AT00954784 T AT 00954784T AT 00954784 T AT00954784 T AT 00954784T AT E289203 T1 ATE289203 T1 AT E289203T1
Authority
AT
Austria
Prior art keywords
conjunctivitis
treatment
proteins
histacalin
effective
Prior art date
Application number
AT00954784T
Other languages
English (en)
Inventor
Patricia Anne Nuttall
Guido Christiaan Paesen
Original Assignee
Evolutec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evolutec Ltd filed Critical Evolutec Ltd
Application granted granted Critical
Publication of ATE289203T1 publication Critical patent/ATE289203T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1767—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855—Proteins from animals other than mammals or birds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855—Proteins from animals other than mammals or birds
    • Y10S530/858—Proteins from animals other than mammals or birds insects; venom

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Surface Treatment Of Glass (AREA)
  • Polarising Elements (AREA)
AT00954784T 1999-09-01 2000-08-24 Behandlung von konjunktivitis mit histacalin proteinen ATE289203T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9920674.0A GB9920674D0 (en) 1999-09-01 1999-09-01 Treatment of conjunctivitis
PCT/GB2000/003282 WO2001015719A2 (en) 1999-09-01 2000-08-24 Treatment of conjunctivitis

Publications (1)

Publication Number Publication Date
ATE289203T1 true ATE289203T1 (de) 2005-03-15

Family

ID=10860170

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00954784T ATE289203T1 (de) 1999-09-01 2000-08-24 Behandlung von konjunktivitis mit histacalin proteinen

Country Status (17)

Country Link
US (1) US6737399B2 (de)
EP (1) EP1207898B1 (de)
JP (1) JP2003508445A (de)
CN (1) CN1382057A (de)
AT (1) ATE289203T1 (de)
AU (1) AU780773B2 (de)
BR (1) BR0013665A (de)
CA (1) CA2382473A1 (de)
DE (1) DE60018192T2 (de)
DK (1) DK1207898T3 (de)
ES (1) ES2235930T3 (de)
GB (1) GB9920674D0 (de)
HK (1) HK1046362B (de)
MX (1) MXPA02001807A (de)
NZ (1) NZ517218A (de)
PT (1) PT1207898E (de)
WO (1) WO2001015719A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0307544D0 (en) * 2003-04-01 2003-05-07 Evolutec Ltd Treatment method
GB0809279D0 (en) * 2008-05-21 2008-06-25 Varleigh Ltd Histamine binding protein
KR102789464B1 (ko) * 2015-09-25 2025-04-03 오코겐, 인크. 란피르나제 및/또는 암피나제를 사용하는 바이러스성 결막염의 치료
GB201720505D0 (en) * 2017-12-08 2018-01-24 Volution Immuno Pharmaceuticals Sa Methods for treatment of neuropathic pain

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU725630B2 (en) * 1996-05-18 2000-10-19 Evolutec Limited Vasoactive amine binding molecules
ATE349525T1 (de) * 1997-11-26 2007-01-15 Evolutec Ltd Histamine und serotonine bindende moleküle

Also Published As

Publication number Publication date
US6737399B2 (en) 2004-05-18
US20020151499A1 (en) 2002-10-17
BR0013665A (pt) 2002-05-14
MXPA02001807A (es) 2003-07-14
WO2001015719A2 (en) 2001-03-08
DE60018192D1 (de) 2005-03-24
DE60018192T2 (de) 2005-12-29
GB9920674D0 (en) 1999-11-03
CA2382473A1 (en) 2001-03-08
NZ517218A (en) 2004-10-29
AU780773B2 (en) 2005-04-14
JP2003508445A (ja) 2003-03-04
EP1207898A2 (de) 2002-05-29
DK1207898T3 (da) 2005-06-13
WO2001015719A3 (en) 2001-05-10
ES2235930T3 (es) 2005-07-16
PT1207898E (pt) 2005-05-31
HK1046362A1 (en) 2003-01-10
HK1046362B (en) 2005-09-02
EP1207898B1 (de) 2005-02-16
AU6713900A (en) 2001-03-26
CN1382057A (zh) 2002-11-27

Similar Documents

Publication Publication Date Title
DE69837295D1 (de) Probucolbernsteinsäureester zur Hemmung der Expression von VCAM-1
ATE260332T1 (de) Behandlung von textilien
DE69924607D1 (de) Benzimidazol-derivate als ige-modulatoren
ATE235481T1 (de) Substituierte benzopyranderivate zur behandlung von entzündungen
DE69831134D1 (de) Behandlung von wasser
DE60222671D1 (de) Thienopyrimidinedione und deren verwendung in der behandlung von autoimmunerkrankungen
DE69931975D1 (de) FSH Mimetika zur Behandlung von Infertilität
EP1017402A4 (de) Behandlung des übersäuerten darmsyndroms
TNSN00010A1 (fr) DIPHENYLUREE A SUBSTITUTION ω CARBOXYARYLE SERVANT D'INHIBUTEURS DE RAF KINASE.
DE69821667D1 (de) Kardioverter zur Behandlung von Vorhofflattern
ATE300597T1 (de) Behandlung von geweben
EA200000911A1 (ru) Новые кристаллические формы антивирусного соединения бензимидазола
ATE198895T1 (de) Verwendung von bindungsreagenzien gegen cd23 in der behandlung von autoimmunkrankheiten
TR200200673T2 (tr) Rinovirüs enfeksiyonlarında csaıd'lerin kullanılması
ATE279386T1 (de) Retinoide zur behandlung von emphysem
TR200101756T2 (tr) Protein kinaz inhibitörleri olarak 4,5-pirazinoksindoller.
EP1117431A4 (de) Behandlung von acidose
ATE289203T1 (de) Behandlung von konjunktivitis mit histacalin proteinen
DE60103685D1 (de) Behandlung von Poriomania
DE60016762D1 (de) Behandlung von allergischer rhinitis mit bestimmten vasoaktiven aminbindenden proteinen
DE60122898D1 (de) Aldosteronantagonist und cyclooxygenase-2 hemmer-kombinationstherapie zur verhinderung oder behandlung von entzündungsverwandten kardiovaskulären krankheiten
DE60022125D1 (de) Tiefstkühlen von Waren
ATE226440T1 (de) Zusammensetzung zur behandlung von psoriasis
LU91009B1 (de) Behandlung von Verbrennungen
DE60017136D1 (de) Behandlung von angiogenese-abhängigen erkrankungen mit dextrinsulphat

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1207898

Country of ref document: EP

REN Ceased due to non-payment of the annual fee